Bone cell function, regulation, and communication: a role for nitric oxide.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 7539433)

Published in J Cell Biochem on March 01, 1995

Authors

P Collin-Osdoby1, G A Nickols, P Osdoby

Author Affiliations

1: Department of Biology, Washington University, St. Louis, Missouri 63130, USA.

Articles by these authors

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol (1993) 3.00

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest (1997) 2.37

Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem (2001) 2.02

Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A (1991) 1.65

Osteogenesis in cultures of limb mesenchymal cells. Dev Biol (1979) 1.60

Isolated osteoclasts and their presumed progenitor cells, the monocyte, in culture. J Exp Zool (1982) 1.23

Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci U S A (1994) 1.23

Electron microscopic and biochemical studies of proteoglycan polydispersity in chick limb bud chondrocyte cultures. J Biol Chem (1978) 1.18

Endothelial modulation of vascular relaxation to nitrovasodilators in aging and hypertension. J Pharmacol Exp Ther (1986) 1.14

Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology (1996) 1.08

Reduction in atherosclerotic lesion size in pigs by alphaVbeta3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling. Circ Res (1999) 1.07

Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology (1993) 1.01

Avian osteoblast conditioned media stimulate bone resorption by targeting multinucleating osteoclast precursors. Calcif Tissue Int (1992) 0.99

Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone. J Endocrinol (2000) 0.98

Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J Clin Invest (1999) 0.96

A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. Cancer Res (1998) 0.95

Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology (1998) 0.95

Identification of osteoclast-specific monoclonal antibodies. J Cell Biol (1985) 0.95

Parathyroid hormone as a smooth muscle relaxant. Endocr Rev (1989) 0.93

Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release. I. Effect of Mg2+. Am J Physiol (1990) 0.93

The development of embryonic bone and cartilage in tissue culture. Clin Orthop Relat Res (1983) 0.88

Isolation of avian osteoclasts: improved techniques to preferentially purify viable cells. J Bone Miner Res (1991) 0.88

Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells. J Cell Biochem (1996) 0.88

Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis. J Bone Miner Res (2000) 0.87

Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication. Endocrinology (1999) 0.86

Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion. J Clin Invest (1976) 0.85

Endothelial regulation of cyclic GMP and vascular responses in hypertension. J Pharmacol Exp Ther (1988) 0.85

First bone formation in the developing chick limb. Dev Biol (1981) 0.85

Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure. J Pharmacol Exp Ther (1991) 0.84

A scanning electron microscopic investigation of in vitro osteogenesis. Calcif Tissue Int (1980) 0.84

Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclasts. J Bone Miner Res (1991) 0.84

Parathyroid hormone and calcium: interactions in the control of renin secretion in the isolated, nonfiltering rat kidney. Endocrinology (1991) 0.83

Enhanced expression of alpha v integrin subunit and osteopontin during differentiation of HL-60 cells along the monocytic pathway. Exp Cell Res (1995) 0.83

Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: autocrine NO mediates Ca2+-inhibited bone resorption. Endocrinology (1997) 0.83

Purinergic vasoconstrictor component revealed by moderate cooling in the isolated mesenteric vasculature of Sprague-Dawley rats. J Pharmacol Exp Ther (1992) 0.83

Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension (1992) 0.83

Growth behavior and lineage of isolated and cultured cells derived from giant cell granuloma of the mandible. J Oral Pathol (1985) 0.82

Endothelium-independent linkage of parathyroid hormone receptors of rat vascular tissue with increased adenosine 3',5'-monophosphate and relaxation of vascular smooth muscle. Endocrinology (1986) 0.82

Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology (1992) 0.82

Manganese potentiation of nitric oxide-mediated vascular relaxation. Eur J Pharmacol (1994) 0.82

Osteoclast development in marrow cultured in calvaria-conditioned media. Dev Biol (1988) 0.81

Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry. Clin Exp Metastasis (1999) 0.81

Increased cyclic AMP in cultured vascular smooth muscle cells and relaxation of aortic strips by parathyroid hormone. Eur J Pharmacol (1985) 0.81

Induction of refractoriness to isoproterenol by prior treatment of C6-2B rat astrocytoma cells with cholera toxin. J Cyclic Nucleotide Res (1979) 0.81

Parathyroid hormone-mediated refractoriness of rat kidney cyclic AMP system. Am J Physiol (1979) 0.80

Adhesion of osteoclasts and monocytes to developing bone. J Exp Zool (1982) 0.80

Osteoclast recruitment in response to human bone matrix is age related. Mech Ageing Dev (1992) 0.80

Alternative splicing generates a second isoform of the catalytic A subunit of the vacuolar H(+)-ATPase. Proc Natl Acad Sci U S A (1995) 0.79

An in vivo model system for the study of avian osteoclast recruitment and activity. Bone Miner (1990) 0.78

Role of extracellular magnesium in insulin secretion from rat insulinoma cells. Proc Soc Exp Biol Med (1992) 0.78

Vasodilation of the rat mesenteric vasculature by parathyroid hormone. J Pharmacol Exp Ther (1986) 0.78

Analogue separates biological effects of salmon calcitonin on brain and renal cortical membranes. Eur J Pharmacol (1988) 0.78

Potentiation of cholera toxin-stimulated cyclic AMP production in cultured cells by inhibitors of RNA and protein synthesis. J Biol Chem (1980) 0.78

Regulation of skeletal muscle 6-phosphofructo-1-kinase during aging and development. Mech Ageing Dev (1986) 0.78

Stimulation of craniofacial and intramedullary bone formation by negatively charged beads. J Oral Maxillofac Surg (1990) 0.78

A human homolog of the 150 kD avian osteoclast membrane antigen related to superoxide dismutase and essential for bone resorption is induced by developmental agents and opposed by estrogen in FLG 29.1 cells. Calcif Tissue Int (1997) 0.78

Temperature sensitivity of cyclic AMP production and catecholamine-induced refractoriness in a rat astrocytoma cell line. Proc Natl Acad Sci U S A (1978) 0.78

The development of long bones of the limb: cell and matrix interactions of osteoclasts and monocytes. Prog Clin Biol Res (1982) 0.77

Isolation and characterization of chondrocytes and non-chondrocytes from high-density chick limb bud cell cultures. J Craniofac Genet Dev Biol (1983) 0.77

Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system. J Bone Miner Res (1998) 0.77

Radioiodinated rat parathyroid hormone-(1-34) binds to its receptor on rat osteosarcoma cells in a manner consistent with two classes of binding sites. J Bone Miner Res (1990) 0.77

Parathyroid hormone-induced changes in cyclic nucleotide levels during relaxation of the rabbit [correction of rat] aorta. Life Sci (1987) 0.77

Orchestration of tooth movement. Am J Orthod (1983) 0.77

Potentiation of nitric oxide-mediated vascular relaxation by SC52608, a superoxide dismutase mimic. Proc Soc Exp Biol Med (1995) 0.77

Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension. J Hypertens (1990) 0.76

Correlation of an osteoclast antigen and ruffled border on giant cells formed in response to resorbable substrates. J Bone Miner Res (1990) 0.76

Characterization of the isolated rat mesenteric vascular-intestinal loop preparation. J Pharmacol Toxicol Methods (1992) 0.76

Altered endothelial modulation of vascular tone in aging and hypertension. Blood Vessels (1987) 0.75

Actions of parathyroid hormone in the cardiovascular system. Blood Vessels (1987) 0.75

Effect of 4-methylumbelliferyl-beta-d-xyloside on collagen synthesis in chick limb bud mesenchymal cell cultures. Dev Biol (1982) 0.75

The origin, development and regulation of osteoclasts. Bioessays (1987) 0.75

Regulation of renal adenylate cyclase by parathyroid hormone. Am J Physiol (1980) 0.75

Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity. J Bone Miner Res (1995) 0.75

Evidence for an immunological and functional relationship between superoxide dismutase and a high molecular weight osteoclast plasma membrane glycoprotein. J Cell Biochem (1991) 0.75

The osteoblast and osteoclast cytodifferentiation. Prog Clin Biol Res (1986) 0.75

Reassessment of noradrenergic function in salt-induced hypertension in Dahl rats. Jpn J Pharmacol (1992) 0.75

Regulation of the receptor-mediated cyclic AMP response of kidney to parathyroid hormone in the vitamin D-deficient rat. J Supramol Struct (1978) 0.75

Purification and characterization of an osteoclast membrane glycoprotein with homology to manganese superoxide dismutase. J Cell Biochem (1991) 0.75

Bolton-Hunter reagent as a vital stain for developing systems. Dev Biol (1982) 0.75

Osteoclast formation is related to bone matrix age. Calcif Tissue Int (1991) 0.75

Characterization of a bone-specific alkaline phosphatase in chick limb mesenchymal cell cultures. Dev Biol (1981) 0.75

HL-60 cell differentiation and osteopontin expression. Ann N Y Acad Sci (1995) 0.75

Charged beads: generation of bone and giant cells. J Bone Miner Res (1988) 0.75